Irma Alert and The Digital Immune System: Winners of the Flemingsberg Science Award STARTUP 2024

Sweden’s children and youth are not doing well. Mental health issues, increasing neuropsychiatric disorders, and sociocultural confusion, partly caused by social media, are on the rise. As a result, the level of knowledge among young people is declining, with reading comprehension and mathematics being particularly problematic areas. Irma Alert, the winner of the Flemingsberg Science Award, wants to change this. 

“I am developing a digital environment aimed at taking better care of Sweden’s youth and which can be seen as a contrast to the social environments that to some extent create pressure on young people today. There, they will be able to get help, primarily through nudging and self-help methods, to feel better and thus perform better. It is a way to future-proof Sweden.” – Irma Alert, founder of The Digital Immune System.

“It’s a fact that psychological problems in children have doubled since 1980. Today’s society is hopelessly behind on monitoring and understanding the youth, years behind, and this needs to be changed. A backpack full of basic existing therapeutical methods combined with innovative features can be the gamechanger that the society needs. An experienced founder and an advisory board with broad competence can make this challenging idea fly!” – Johnny Högberg, CEO Flemingsberg Science Foundation.

See the full interview with Irma Alert.

Press Start: The Game Hub in Flemingsberg – Finally!

On April 24th, after just two months of hard work, it was finally time for the kick-off for the game cluster Press Start. The initiative is led by Drivhuset, in close collaboration with Flemingsberg Science Foundation and Södertörn University's Innovation Station.

AlzeCure Pharma – a hope in the fight against Alzheimer’s

Neurological diseases and the pain area are struggling with great medical needs, including the lack of broad-spectrum drugs. Those are gaps in the market that AlzeCure Pharma wants to fill, and they are well on their way. They recently received a grant from the European Innovation Council (EIC) to finance a clinical phase 2 study of the drug candidate NeuroRestore ACD856 for Alzheimer’s disease.

Kick-off Cluster Engine Life Science Flemingsberg!

At the end of last year, the Flemingsberg Science Foundation was granted funding from the European Regional Development Fund (ERDF) for the project Cluster Engine Life Science Flemingsberg, which aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. Recently, it was time for the official launch – and what a grand launch it was!

Go to Top